Cost-Effectiveness of Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine in the Italian Adult Population

The availability of a new 20-valent pneumococcal conjugate vaccine (PCV) makes it appropriate to assess its cost-effectiveness. This was evaluated by adopting the Italian National Health Service perspective, using a cost consequences Markovian model. The expected effects of vaccination with 20-valen...

Descripción completa

Detalles Bibliográficos
Autores principales: Polistena, Barbara, Icardi, Giancarlo, Orsi, Andrea, Spandonaro, Federico, Di Virgilio, Roberto, d’Angela, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784405/
https://www.ncbi.nlm.nih.gov/pubmed/36560441
http://dx.doi.org/10.3390/vaccines10122032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784405/
https://www.ncbi.nlm.nih.gov/pubmed/36560441
http://dx.doi.org/10.3390/vaccines10122032

Ejemplares similares